Revenue rose to $75.3 million for the quarter, driven by new licensing deals and initial REDEMPLO sales, but higher R&D and commercialization costs led to a net loss of $194.3 million. The company strengthened its balance sheet with $930 million in new financing and expanded its global footprint th…
Revenue rose to $75.3 million for the quarter, driven by new licensing deals and initial REDEMPLO sales, but higher R&D and commercialization costs led to a net loss of $194.3 million. The company strengthened its balance sheet with $930 million in new financing and expanded its global footprint through major partnerships and regulatory approvals.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
